Skip to main content
. Author manuscript; available in PMC: 2016 Jan 26.
Published in final edited form as: J Diabetes Metab. 2015 May 30;6(6):555. doi: 10.4172/2155-6156.1000555

Figure 3.

Figure 3

Urinary TBARs excretion (A) and MCP-1 excretion (B) in streptozotocin-induced diabetic mice. Both urinary TBARs and MCP-1 excretion levels were significantly elevated in diabetic versus control mice (*P<0.05 vs. control mice). Only baicalein treatment for 10 weeks significantly reduced TBARs excretion in diabetic mice (#P<0.05 vs. diabetic mice, n=6-8/ group).